Trial Profile
Efficacy and toxicity of pembrolizumab in patients with solid tumors: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 21 Jan 2016 New trial record